Abstract

Changes in legislation have affected supply routes of new psychoactive substances such as synthetic cannabinoids with evidence of supply over the darknet. We identified darknet drug markets using an index database and Tor Browser to access markets. We identified SC in product listings using a custom-programmed script. We collected data at bimonthly intervals (August 2016–April 2017). Eleven darknet markets listed SC for sale, the largest number from China, UK, US, Netherlands, and Germany. Formulations available were high purity powder/crystal, smoking preparations and vape preparations. The top five listed compounds from China across the time points were FUB-AMB, ABD-FUBINACA, 5F-NPB-22, MAB-CHMINACA, and NM-2201. 5F-CUMYL-4CN-PINACA was unavailable at early time points but emerged during the study. Cost of high purity formulations from China ranged from 1.3 to 3.1 Euro per gram for quantities ≥1000 g. Europe and North America accounted for 99% smoking preparations predominantly in small packages (<50 g). SC are widely available on the darknet with availability changing over time. High purity formulations are predominantly available from China in quantities up to kilograms with price per gram reducing with increased quantity. Small packages of ready-made smoking mixtures are available from Europe and North America.

Details

Title
Synthetic cannabinoid availability on darknet drug markets—changes during 2016–2017
Author
Scourfield, Andrew 1 ; Flick, Catherine 2 ; Ross, Jack 1 ; Wood, David M 3   VIAFID ORCID Logo  ; Thurtle, Natalie 4   VIAFID ORCID Logo  ; Stellmach, Darryl 5   VIAFID ORCID Logo  ; Dargan, Paul I 3 

 Clinical Toxicology, Guys and St Thomas’ NHS Foundation Trust, London, UK; 
 Centre for Computing and Social Responsibility, De Montfort University, Leicester, UK; 
 Clinical Toxicology, Guys and St Thomas’ NHS Foundation Trust, London, UK;; Faculty of Life Sciences and Medicine, King’s College London, London, UK; 
 Emergency Medicine and Clinical Toxicology, Prince of Wales Hospital, Sydney, NSW, Australia; 
 The Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, NSW, Australia;; Médecins Sans Frontières—UK, London, UK 
End page
15
Publication year
2019
Publication date
Dec 2019
Publisher
Taylor & Francis Ltd.
e-ISSN
24734306
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2353414305
Copyright
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.